Searched for
SUCHITRA ELLA
Tata Chemicals CEO R Mukundan takes over as CII president for 2026-27R Mukundan, CEO of Tata Chemicals, has assumed the presidency of the Confederation of Indian Industry (CII) for 2026-27, succeeding Rajiv M...- Covaxin booster dose approved by Japan, says Bharat Biotech"We are proud to announce, Japan has approved COVAXIN booster dose for travellers. Another global recognition of the effectiveness of our u...
- Padma Bhushan to Satya Nadella, Sundar Pichai, N ChandrasekaranThe Padma Bhushan is India's third-highest civilian award behind the Bharat Ratna and the Padma Vibhushan.
- Privileged to be on illustrious list: SII's Poonawalla after being awarded Padma BhushanSerum Institute of India managing director Dr Cyrus S Poonawalla, who was awarded the Padma Bhushan on Tuesday, said it was a great privile...
- Padma Awards: Padma Vibhushan for late CDS Bipin Rawat, Kalyan Singh; Neeraj Chopra gets Padma ShriVeteran politician Kalyan Singh will receive the Padma Vibhushan posthumously. Also, late Communist leader and West Bengal chief minister B...
- Bharat Biotech chairman donates Rs two crore to Tirumala Tirupati Devasthanams run trustThe official further said the devotees requested the TTD to utilise the donation amount for the temple-run pilgrim free meal trust called S...
- Bharat Biotech proud of contribution to historic landmark: Dr Krishna Ella on COVID vaccination coverage crossing 100 cr markTerming the achievement as a "true success story of Atmanirbharta", he said that it was a unified effort of the government, vaccine manufac...
- Bharat Biotech's Suchitra Ella says vaccines shouldn't be a barrier to enter any nation if approved by national regulatory authoritiesIndia has not been able to make it in the list of countries whose vaccinations will be accepted in the UK from next month. The UK has said ...
- Bharat Biotech commits to supply 500 million doses of Covaxin to Centre for immunisation programmeSpeaking at a virtual conference organised by the Confederation of Indian Industry, Suchitra Ella, joint Managing Director of the city-base...
- Inching towards EUL by WHO for Covaxin: Bharat Biotech"We are working closely with the World Health Organisation for inclusion of Covaxin in its Emergency Use Listing. Approval from WHO is not ...
- Pre-submission meet held, Covaxin's 'rolling data' to start in July: WHOMeanwhile, stating that its COVID-19 vaccine Covaxin adheres to international standards, Bharat Biotech's joint managing director Suchitra ...
- Bharat Biotech supplies Covaxin to 16 statesCompany's co-founder and joint managing director Suchitra Ella on Wednesday tweeted that Andhra Pradesh, Assam, Delhi, Gujarat, Karnataka, ...
- Covaxin reached 30 cities in 30 days: Bharat Biotech's Joint MD Suchitra EllaBy way of dispatch to private hospitals, the vaccine has reached various cities, including Amritsar, Bangalore, Chennai, Delhi, Ernakulam, ...
- Covaxin dispatched to various states like Gujarat, Assam: Bharat Biotech"Covaxin goes to Gandhinagar, Guwahati, Chennai, Hyderabad, Bengaluru & Bhuvneshwar. thank all our employees @ BHarat bio who worked thru t...
- 50 employees Bharat Biotech test COVID-19 positive; Joint MD's tweet draws bouquets and brickbatsThe Hyderabad-based firm is supplying Covaxin to 18 states, including Andhra Pradesh, Haryana, Odisha, Assam, Jammu & Kashmir, Tamil Nadu, ...
- Bharat Biotech commences direct supply of 'Covaxin' to 14 statesThe company is supplying vaccines to Andhra Pradesh, Assam, Chhattisgarh, Gujarat, Jammu & Kashmir, Jharkhand, Madhya Pradesh, Odisha, Tami...
- CK Ranganathan elected chairman of CII-SR, Bharat Biotech co- founder Suchitra K Ella deputyHyderabad-based Bharat Biotech International co-founder Suchitra K Ella was elected as deputy chairperson on Saturday, a release from the i...
- 65% of vaccines manufactured in Hyderabad, says Bharat Biotech's Krishna EllaKrishna Ella, whose firm developed India's first indigenous vaccine for Covid-19, said 'pandemic vaccines and everything in future will com...
- 13,000 volunteers administered 2nd dose of Covaxin in phase-3 trials: Bharat BiotechCovaxin is India's totally indigenous COVID-19 vaccine developed in collaboration with the Indian Council of Medical Research and National ...
- ICICI Ventures, IFC may exit Bharat Biotech; transaction may value company at 1000 croreInvestment banker Avendus has been mandated by ICICI Ventures to find suitors and the initial process has begun, sources in the know said.
Load More
